World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
FDA Sets Path for Biotech Drug Copies
Keywords:
The FDA sets a pathway for developing "biosimilar" drugs in the U.S. Biosimilar drugs are cheaper versions of higher cost biotech drugs. Europe has moved further ahead in this area.
The U.S. FDA and a pathway for developing biosimilar drugs to reduce healthcare cost
02/10/2012
Grouped Articles
FDA Sets Path for Biotech Drug Copies
Wall Street Journal 02/10/2012
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
Biotech Drugs Still Won't Copy
Wall Street Journal 02/27/2013
Biotech industry and protection from generic replacements.
03/14/2007
Grouped Articles
Will Rising Prices for Some Generic Drugs Never End?
Wall Street Journal 11/14/2014
For Booming Biotech Firms, A New Threat: Generics
Wall Street Journal 03/14/2007
BusinessWeek 04/09/2007
Blood Boils Over Bill To Protect Biotech Drugs
Wall Street Journal 07/13/2009
Wall Street Journal 01/13/2011
Firms Push for Biotech Generics
Wall Street Journal 01/26/2011
Biotech pharmaceutical startups wither in the new economic climate- 2007-2010
04/09/2007
Biotech starups are running short of cash in large numbers and some are in bankruptcy liquidation.
Grouped Articles
Wall Street Journal 07/01/2013
BusinessWeek 04/09/2007
Cash-Poor Biotech Firms Cut Research, Seek Aid
Wall Street Journal 10/29/2008
Big Pharma's Costly Debt Addiction
Wall Street Journal 02/09/2009
Cash Dries Up for Biotech Drug Firms
Wall Street Journal 03/16/2009
High-Tech Auctions Crowd Silicon Valley
Wall Street Journal 03/16/2009
U.S. biotech companies and industry
01/13/2011
Grouped Articles
Wall Street Journal 07/01/2013
Wall Street Journal 07/01/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Wall Street Journal 07/25/2015
Wall Street Journal 09/29/2015
Wall Street Journal 11/22/2011
Biotech pharmaceutical companies and industry.
03/14/2007
Grouped Articles
Wall Street Journal 07/01/2013
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12/16/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
For Booming Biotech Firms, A New Threat: Generics
Wall Street Journal 03/14/2007
BusinessWeek 04/09/2007
India's Biotech companies
01/13/2011
Makers of insulin and other biotech companies in India.
Grouped Articles
Wall Street Journal 07/01/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
From Brewing, an Indian Biotech Is Born
BusinessWeek 02/24/2011
As U.N. Meets, a Battle Over Generic Biotech Drugs
New York Times 09/18/2011
Why India should scare Silicon Valley - The Washington Post
Washington Post 11/29/2011
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
